Recent blog posts
What are ACE2 inhibitor and how do you quickly get the latest development progress?
What are ACE2 inhibitor and how do you quickly get the latest development progress?
13 November 2023
ACE inhibitors are a class of drugs that work by relaxing blood vessels, inhibiting the production of the vasoconstrictor substance Angiotensin II. This results in lower blood pressure, reduced cardiac load, and decreased risk of hypertension.
Read →
T-cell co-stimulation target: 4-1BB (CD137)
T-cell co-stimulation target: 4-1BB (CD137)
10 November 2023
4-1BB (also known as CD137 or TNFRSF9) was first discovered in 1989 and is a critical co-stimulation receptor on T cells and other immune cells.
Read →
Latest Research Progress on TLR Adjuvants
Latest Research Progress on TLR Adjuvants
10 November 2023
The TLR agonists used in vaccine formulations come in various forms, ranging from lipopeptides to single-stranded DNA and RNA.
Read →
New Generation Vaccine Adjuvant: TLR Agonists
New Generation Vaccine Adjuvant: TLR Agonists
10 November 2023
TLRs are innate immune receptors that are responsible, directly or indirectly, for detecting pathogen-associated molecular patterns (PAMPs) and responding to them through the activation of innate and adaptive immune pathways.
Read →
Analysis on the Research Progress of Endothelin Receptor Antagonist
Analysis on the Research Progress of Endothelin Receptor Antagonist
9 November 2023
Endothelin receptor are G protein-coupled receptors (GPCRs) of the β-group of rhodopsin receptors that bind to endothelin ligands, which are 21 amino acid long peptides derived from longer prepro-endothelin precursors.
Read →
Analysis on the Research Progress of D2 Receptor Agonist
Analysis on the Research Progress of D2 Receptor Agonist
8 November 2023
The D2 receptor is a type of dopamine receptor found in the human body. It plays a crucial role in various physiological and neurological processes.
Read →
Analysis on the Clinical Research Progress of Factor Xa Inhibitor
Analysis on the Clinical Research Progress of Factor Xa Inhibitor
6 November 2023
Factor Xa is a key protease of the coagulation pathway whose activity is known to be in part modulated by binding to factor Va and sodium ions.
Read →
Advances in Clinical Research on Cyclin-dependent Kinase Inhibitor
Advances in Clinical Research on Cyclin-dependent Kinase Inhibitor
6 November 2023
CDKs or cyclin-dependent kinase,are a group of enzymes that play a crucial role in regulating the cell cycle in the human body.
Read →
Analysis on the Research Progress of Dihydrofolate Reductase Inhibitor
Analysis on the Research Progress of Dihydrofolate Reductase Inhibitor
6 November 2023
DHFR, or dihydrofolate reductase, is an indispensable enzyme required for the survival of most prokaryotic and eukaryotic cells as it is involved in the biosynthesis of essential cellular components.
Read →
Analysis on the Clinical Research Progress of FcRn Antagonists
Analysis on the Clinical Research Progress of FcRn Antagonists
3 November 2023
FcRn, or neonatal Fc receptor, is a crucial protein found in the human body that plays a significant role in the immune system and the pharmacokinetics of therapeutic antibodies.
Read →
Analysis on the Clinical Research Progress of ERK Inhibitor
Analysis on the Clinical Research Progress of ERK Inhibitor
2 November 2023
ERK, also known as Extracellular Signal-Regulated Kinase, is a crucial protein kinase that plays a significant role in various cellular processes within the human body.
Read →
Advances in Clinical Research on D2 Receptor Antagonist
Advances in Clinical Research on D2 Receptor Antagonist
2 November 2023
The D2 receptor is a type of dopamine receptor found in the human body. It plays a crucial role in various physiological and neurological processes.
Read →